[ Price : $8.95]
Alexza Pharmaceuticals submits an NDA to FDA for its Staccato loxapine inhalation drug for treating agitation in patients with sch...[ Price : $8.95]
FDA updates drug shortage and discontinuation information for methotrexate injection, mitomycin for injection and Vesanoid respect...[ Price : $8.95]
FDA grants BiPar Sciences fast track status for BSI-201 for treating metastatic triple-negative breast cancer.[ Price : $8.95]
FDA approves a Lannett ANDA for a generic copy of Purdue Pharmaceuticals' Dilaudid tablets.[ Price : $8.95]
FDA asks the Endocrinologic & Metabolic Drugs Advisory Committee to comment on safety concerns from a trial of AstaZenecas Crestor...[ Price : $8.95]
Senators stake out opposing positions on drug importation and threaten to block consideration of overall healthcare reform legisla...[ Price : $8.95]
Federal Register Final rule: FDA amends its animal drug regulations to reflect a NADA sponsor change to Janssen Pharmaceutica.[ Price : $8.95]
Federal Register Proposed rule: FDA extends the comment period for a proposed rule requesting comments on postmarketing safety rep...